Emphysema

J10_EMPHYSEMA

pleural empyema: The presence of pus in the thoracic cavity, between the visceral and parietal pleura. [database_cross_reference: NCIT:P378]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J43 Hospital discharge: ICD-9 — 492 Hospital discharge: ICD-8 — 492 Cause of death: ICD-10 — J43 Cause of death: ICD-9 — 492 Cause of death: ICD-8 — 492 2 out of 7 registries used, show all original rules.	3076
4. Check minimum number of events None	3076
5. Include endpoints None	3076
6. Filter based on genotype QC (FinnGen only)	2997

Control definitions (FinnGen only)

Control exclude: J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Emphysema pulmonale

NAME	J10_EMPHYSEMA
CONTROL_EXCLUDE	J10_LOWCHRON
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J43
HD_ICD_9	492
HD_ICD_8	492
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J43
COD_ICD_9	492
COD_ICD_8	492
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Emphysema based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	25262	6005	18635
Only index persons	14435	4338	10097
Unadjusted period prevalence (%)
Whole population	0.44	0.17	0.52
Only index persons	0.32	0.16	0.39
Median age at first event (years)
Whole population	68.18	67.77	68.36
Only index persons	67.82	66.92	68.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2997	809	2188
Unadjusted period prevalence (%)	0.81	0.29	1.00
Median age at first event (years)	69.86	66.72	71.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3076: Matched controls
30757

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R96

ICPC

Asthma

13.2

320.8

317

265

R03BA01

ATC

beclometasone; inhalant

7.1

315.5

527

868

R03BB01

ATC

ipratropium bromide; inhalant

12.1

307.9

322

294

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

11.0

307.7

405

420

J96.1

ICD-10 Finland

Chronic respiratory failure

37.3

307.7

381

116

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

349.8

307.7

929

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

237.5

307.7

447

J45

ICD-10 Finland

Asthma

16.2

307.7

317

216

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

200.6

307.7

1723

194

R03AK06

ATC

salmeterol and fluticasone; inhalant

17.1

307.7

950

785

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

751.8

307.7

652

R03AC13

ATC

formoterol; inhalant

30.4

307.7

295

107

R95

ICPC

Chron obstructive pulmonary disease

82.4

307.7

445

J43.8

ICD-10 Finland

Other emphysema

3744.9

307.7

345

H02AB06

ATC

prednisolone; systemic

5.0

307.7

1996

8325

R06.0

ICD-10 Finland

Dyspnoea

4.4

307.7

1344

4591

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

307.7

437

J43.9

ICD-10 Finland

Emphysema, unspecified

6123.7

307.7

2112

R03AC02

ATC

salbutamol; inhalant

7.2

307.7

2158

7595

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

127.7

307.7

236

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

62.7

307.7

336

J45.0

ICD-10 Finland

Predominantly allergic asthma

95.0

307.7

269

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

16.3

307.7

322

219

R03AK07

ATC

formoterol and budesonide; inhalant

6.7

307.7

829

1607

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

307.7

1239

R03BB04

ATC

tiotropium bromide; inhalant

58.7

307.7

1415

440

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

12.1

307.7

525

515

R03AK03

ATC

[U] fenoterol and ipratropium bromide

13.4

307.7

504

443

J45.1

ICD-10 Finland

Nonallergic asthma

151.1

307.7

384

UGC12

NOMESCO Finland

Flexible bronchoscopy

7.9

307.7

690

1085

R03DA04

ATC

theophylline; systemic, rectal

19.8

307.7

495

295

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

55.5

307.7

328

R03BA02

ATC

budesonide; inhalant

6.6

307.7

632

1156

R03AC12

ATC

salmeterol; inhalant

49.7

307.7

297

J45.9

ICD-10 Finland

Asthma, unspecified

38.1

307.7

888

324

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.6

307.7

926

1643

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

189.0

307.7

724

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

307.7

1556

5872

R02

ICPC

Shortness of breath/dyspnoea

5.3

292.4

704

1635

R03AK08

ATC

formoterol and beclometasone; inhalant

28.9

281.8

190

R03DC03

ATC

montelukast; oral

6.1

251.1

482

905

R03BA05

ATC

fluticasone; inhalant

5.1

249.1

602

1391

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

12.0

244.9

255

230

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

33.9

242.6

155

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

11.3

230.6

249

237

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.6

224.0

628

1629

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.3

216.4

483

1036

GD1AD

NOMESCO Finland

Thorax CT examination

6.1

216.2

413

768

XG410

NOMESCO Finland

Flow-volume spirometry

9.1

208.3

265

315

R03AC03

ATC

terbutaline; inhalant

5.3

206.1

457

973

N07BA03

ATC

varenicline; oral

8.5

204.9

276

352

R03AC18

ATC

indacaterol; inhalant

92.3

204.4

107

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

189.6

1870

10457

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.9

188.9

367

691

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.3

179.4

222

254

R03BA08

ATC

ciclesonide; inhalant

7.1

171.6

270

410

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

35.7

170.3

107

J01MA14

ATC

moxifloxacin; systemic

4.5

169.9

470

1193

J47

ICD-10 Finland

Bronchiectasis

438.5

168.3

167

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.4

167.3

747

2640

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

20.0

164.1

127

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

13.7

157.8

149

114

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

14.8

157.7

142

100

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8.3

153.1

207

264

J43.1

ICD-10 Finland

Panlobular emphysema

+∞

148.1

141

R04.2

ICD-10 Finland

Haemoptysis

6.3

146.4

259

443

J45.8

ICD-10 Finland

Mixed asthma

301.5

141.7

143

TGC00

NOMESCO Finland

Bronchial lavation

8.3

138.4

187

238

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

136.5

557

1842

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

133.8

842

3576

H02AB07

ATC

prednisone; oral

3.4

130.2

539

1795

R03AK11

ATC

formoterol and fluticasone; inhalant

18.5

129.9

104

J46

ICD-10 Finland

Status asthmaticus

200.0

129.7

134

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

15.1

125.8

112

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.8

123.0

237

439

C03CA01

ATC

furosemide; systemic

2.4

114.1

1401

8057

Z72.0

ICD-10 Finland

Tobacco use

7.7

107.3

153

207

R28

ICPC

Limited function/disability (R)

12.3

105.0

105

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

101.4

764

3494

R03BB07

ATC

umeclidinium bromide; inhalant

33.2

101.3

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

35.7

100.3

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

97.4

J01AA02

ATC

doxycycline; systemic

2.5

97.1

2385

17856

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

174.0

96.8

101

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

96.3

1507

9383

XG466

NOMESCO Finland

Sleep oxymetry

5.9

91.5

170

303

J01MA12

ATC

levofloxacin; systemic

2.4

91.0

776

3737

J01FA06

ATC

roxithromycin; oral

2.1

85.8

1200

7065

J42

ICD-10 Finland

Unspecified chronic bronchitis

20.7

85.6

XG405

NOMESCO Finland

Education on PEF monitoring

14.7

84.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.3

81.7

171

340

348

Kela drug reimbursment

Roflumilast

+∞

80.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

80.3

522

2199

J43

ICD-10 Finland

Emphysema

278.2

79.9

49300

ICD-8 Finland

Asthma, bronchiale

+∞

76.4

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

16.2

76.2

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

136.8

75.3

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

19.7

74.7

R03DX07

ATC

roflumilast; oral

+∞

72.2

H02AB04

ATC

methylprednisolone; systemic

2.7

70.7

429

1739

R06.2

ICD-10 Finland

Wheezing

5.5

70.3

140

266

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.9

68.9

126

221

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

6.1

68.5

121

205

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

86.6

68.3

J93.9

ICD-10 Finland

Pneumothorax, unspecified

14.4

68.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

68.2

769

4102

SPAT1059

SPAT

Spirometry at the office

4.4

68.1

177

421

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

8.1

67.0

116

R81

ICPC

Pneumonia

4.4

66.7

175

419

GX1K5

NOMESCO Finland

Diffusion capacity

19.9

66.0

A07AA02

ATC

nystatin; oral

3.6

65.8

233

691

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

4.9

61.3

137

288

J20

ICD-10 Finland

Acute bronchitis

2.9

61.0

312

1152

XG460

NOMESCO Finland

Short time oxymetry

6.5

60.7

101

161

49209

ICD-8 Finland

Emphysema, Unspecified

+∞

60.6

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

59.6

J43.0

ICD-10 Finland

MacLeod syndrome

+∞

59.6

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.2

58.2

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

578.7

57.8

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

5.8

57.4

107

191

C07AB07

ATC

bisoprolol; oral

1.8

55.3

1707

12535

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.1

55.1

117

235

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.4

54.9

204

623

A02BC02

ATC

pantoprazole; systemic

1.8

54.3

2014

15591

I50.0

ICD-10 Finland

Congestive heart failure

2.5

54.2

383

1661

R03BB06

ATC

glycopyrronium bromide; inhalant

77.9

54.2

R03AC19

ATC

olodaterol

100.3

54.0

WX725

NOMESCO Finland

Noninvasive ventilation

3.4

53.8

207

646

N02AX02

ATC

tramadol; systemic, rectal

1.8

52.5

1351

9350

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

51.6

963

6038

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.7

51.1

126

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

16.1

50.4

J98.1

ICD-10 Finland

Pulmonary collapse

12.8

49.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

49.5

433

2060

Z2446

NOMESCO Finland

Social worker

3.0

48.8

226

787

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

48.3

724

4212

R03DC01

ATC

zafirlukast; oral

11.8

48.1

N05CF01

ATC

zopiclone; oral

1.8

47.3

1048

6886

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

6.1

47.2

140

P17

ICPC

Tobacco abuse

8.3

47.1

4920A

ICD-9 Finland

Emphysematous bleb

+∞

47.0

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

13.5

46.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

46.3

1017

6655

J96.0

ICD-10 Finland

Acute respiratory failure

6.0

46.0

140

GX2C5

NOMESCO Finland

Short-lasting oximetry

17.0

44.5

M05BA04

ATC

alendronic acid; oral

2.6

43.6

281

1162

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

12.4

43.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

42.8

115

280

R05

ICPC

Cough

1.9

42.0

614

3523

R29

ICPC

Respiratory symptom/complaint other

3.0

41.9

194

675

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

7.6

41.6

SPAT1058

SPAT

PEF monitoring instruction

2.9

41.4

208

757

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

4.3

41.3

110

266

R4110

NOMESCO Finland

Physiotherapy

1.8

41.0

830

5269

R03BB02

ATC

oxitropium bromide; inhalant

11.5

40.5

WX892

NOMESCO Finland

Monitored bed care

2.4

40.2

292

1276

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.2

40.2

108

263

R05CB01

ATC

acetylcysteine; inhalant, oral

5.9

40.1

124

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

6.7

39.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

39.7

284

1232

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

39.7

533

2967

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

39.5

233

922

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.1

39.4

116

ZXD05

NOMESCO Finland

Urgent procedure

1.7

39.1

922

6098

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

38.6

XG474

NOMESCO Finland

Exhalation nntrogen oxide

7.2

38.1

A01AB09

ATC

miconazole; local oral

2.5

37.9

261

1112

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

37.2

228

919

J98.2

ICD-10 Finland

Interstitial emphysema

83.2

36.9

J01CA04

ATC

amoxicillin; systemic

1.7

36.8

2171

18053

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.9

36.8

172

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

36.4

960

6522

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

69.1

36.0

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.0

35.9

160

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

3.1

35.9

155

518

WX721

NOMESCO Finland

Oxygen concentrator therapy

48.4

35.7

A02BC01

ATC

omeprazole; systemic

1.7

35.3

837

5516

N02AA01

ATC

morphine; systemic, rectal

3.8

35.2

110

299

N02AA05

ATC

oxycodone; systemic

1.8

35.2

641

3920

R06AE07

ATC

cetirizine; oral

1.7

34.9

978

6735

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

34.4

4928X

ICD-9 Finland

Emphysema, Other emphysema[EMPHYSEMA ALIA DEFINITA]

+∞

34.4

J01FA09

ATC

clarithromycin; systemic

1.7

34.4

722

4597

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

34.3

853

5688

J01FF01

ATC

clindamycin; systemic

1.7

34.2

771

5006

TGD00

NOMESCO Finland

Needle biopsy of lung

9.6

34.2

Z3226

NOMESCO Finland

Physiotherapist

1.9

34.2

540

3158

Z94.2

ICD-10 Finland

Lung transplant status

42.5

34.0

N03AX16

ATC

[U] pregabalin

1.8

33.4

645

4005

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

33.0

225

953

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

33.0

183

701

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

32.7

625

3865

ZXE00

NOMESCO Finland

One hour or less

1.6

32.2

1082

7759

N05BA04

ATC

oxazepam; oral

1.7

32.1

721

4664

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

32.0

843

5688

GDC00

NOMESCO Finland

Lobectomy of lung

8.1

32.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

31.7

339

1731

SPAT1060

SPAT

Administration of oxygen

12.0

31.6

A03

ICPC

Fever

2.0

31.1

363

1913

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

7.0

31.0

J37.0

ICD-10 Finland

Chronic laryngitis

3.4

30.9

112

336

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

9.3

30.9

GDG10

NOMESCO Finland

Bilateral transplantation of lung

46.8

30.6

49202

ICD-8 Finland

Emphysema, Focale (bullosum)

+∞

30.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

30.2

766

5107

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.0

30.2

134

455

Z3231

NOMESCO Finland

Registered nurse

1.7

30.2

801

5403

Z51.5

ICD-10 Finland

Palliative care

2.1

29.8

324

1664

N06AX11

ATC

mirtazapine; oral

1.6

29.7

873

6035

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

35.0

29.6

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

29.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

28.9

895

6258

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

28.2

28.9

L04AA06

ATC

mycophenolic acid; systemic

4.5

28.8

162

A02BC03

ATC

lansoprazole; oral

1.6

28.6

826

5679

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

7.4

28.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

28.3

926

6553

N07BB01

ATC

disulfiram; oral

3.0

28.3

128

439

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

28.3

406

2293

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

28.3

310

1596

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

28.2

442

2566

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

28.2

N06AB04

ATC

citalopram; systemic

1.7

27.9

551

3424

R78

ICPC

Acute bronchitis/bronchiolitis

4.4

27.8

158

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

27.5

413

2365

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.2

27.4

181

N05CD07

ATC

temazepam; oral

1.8

27.3

427

2477

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.4

27.1

49201

ICD-8 Finland

Emphysema, Generale bronchitide non indicata

+∞

27.1

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

27.1

153

592

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

26.8

348

1900

J96.9

ICD-10 Finland

Respiratory failure, unspecified

7.3

26.7

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

26.7

184

783

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

26.7

292

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

4.8

26.7

127

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

8.6

26.6

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.7

26.6

131

SPAT1254

SPAT

Administration of medicine

1.8

26.3

447

2656

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

26.3

545

3428

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.5

26.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

26.0

376

2126

C03DA01

ATC

spironolactone; oral

1.8

25.9

411

2391

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

25.7

222

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

3.9

25.3

192

A28

ICPC

Limited function/disability NOS

1.7

25.3

598

3891

N03AX12

ATC

[U] gabapentin; oral

1.8

25.2

437

2611

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

25.0

149

592

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

24.9

883

6333

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.3

24.6

148

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

24.6

105

349

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

24.5

149

598

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

24.5

250

1252

A02BA02

ATC

ranitidine; systemic

1.7

24.4

596

3907

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.5

24.2

152

619

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

24.1

620

4117

AN1

Coronary angiography

1.8

23.9

434

2624

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

23.8

793

5596

WX730

NOMESCO Finland

Conventional respirator

3.9

23.6

184

N06AB10

ATC

escitalopram; oral

1.8

23.5

419

2521

4928A

ICD-9 Finland

Emphysema, Other emphysema[EMPHYSEMA SINE BRONCHITIDE]

+∞

22.9

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

22.9

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

5.4

22.8

127

Kela drug reimbursment

Transplant complication

4.4

22.7

132

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

26.1

22.6

J01FA15

ATC

telithromycin; oral

2.1

22.2

225

1123

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

22.1

382

2274

N05BA01

ATC

diazepam; systemic, rectal

1.8

22.1

360

2108

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

29.3

21.8

N06AX12

ATC

bupropion; oral

2.7

21.8

116

435

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

25.2

21.7

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.0

21.7

Z2221

NOMESCO Finland

Medical doctor

1.6

21.6

706

4947

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.1

21.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

21.5

611

4144

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

21.4

319

1816

JN4AD

NOMESCO Finland

Body CT examination

1.8

21.4

334

1929

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

21.3

133

540

GX2D5

NOMESCO Finland

Sleep oximetry

7.3

21.2

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

34.0

21.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

21.0

132

538

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

20.9

154

675

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

20.9

J86.9

ICD-10 Finland

Pyothorax without fistula

4.8

20.8

100

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.7

1124

8722

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.2

20.7

261

R05

ICD-10 Finland

Cough

1.6

20.5

493

3206

B01AC04

ATC

clopidogrel; oral

1.6

20.5

600

4092

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.3

20.5

232

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

20.3

1001

7617

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

5.9

20.1

J93.8

ICD-10 Finland

Other pneumothorax

6.6

20.0

WW200

NOMESCO Finland

Immunization

3.1

19.9

267

SPAT1057

SPAT

Peak expiratory flow measurement

4.6

19.8

104

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

36.0

19.8

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.0

19.7

306

R24

ICPC

Haemoptysis

6.7

19.6

I50

ICD-10 Finland

Heart failure

2.5

19.6

126

520

C01DA14

ATC

isosorbide mononitrate; oral

1.5

19.5

645

4517

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

19.5

344

2058

J12.8

ICD-10 Finland

Other viral pneumonia

5.1

19.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

19.4

693

4932

A06AD11

ATC

lactulose; oral

1.6

19.4

523

3497

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.7

19.3

163

WX722

NOMESCO Finland

PEEP

2.3

19.3

148

661

N05AA02

ATC

levomepromazine; systemic

2.4

19.3

128

536

N06AX16

ATC

venlafaxine; oral

1.9

19.2

278

1566

A02BC05

ATC

esomeprazole; systemic

1.4

19.2

1029

7938

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

19.2

473

3093

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

19.1

132

562

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

19.0

143

633

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

34.5

18.9

WX882

NOMESCO Finland

High dependency care

2.7

18.9

369

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

18.8

931

7071

49099

ICD-8 Finland

Bronchitis, unspecified

+∞

18.8

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

18.8

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

6.8

18.7

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.7

18.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

18.4

253

1402

5120A

ICD-9 Finland

Pneumothorax, Spontaneous tension pneumothorax

15.1

18.4

R03BB05

ATC

aclidinium bromide; inhalant

30.2

18.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

18.2

408

2603

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

18.1

1077

8444

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

18.1

142

640

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

18.1

139

621

ZX108

NOMESCO Finland

Inhalation

5.5

17.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

17.9

157

741

N06AA09

ATC

amitriptyline; systemic

1.9

17.7

253

1419

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

67.0

17.7

R03DA05

ATC

aminophylline; systemic, rectal

6.2

17.6

JN4BD

NOMESCO Finland

Extensive body CT

1.7

17.6

336

2054

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

95.6

17.6

J18

ICD-10 Finland

Pneumonia, organism unspecified

4.9

17.6

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.9

17.4

51299

ICD-8 Finland

Spontaneous pneumothorax

7.8

17.4

AA1AD

NOMESCO Finland

CT of head and brain

1.5

17.3

830

6244

SPAT1263

SPAT

Sampling

1.4

17.3

1060

8337

RK110, ,

NOMESCO Finland

5.7

17.3

R52.9

ICD-10 Finland

Pain, unspecified

1.9

17.2

240

1337

J41.0

ICD-10 Finland

Simple chronic bronchitis

14.9

17.1

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.7

17.1

144

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

6.6

17.0

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.2

17.0

109

284

Kela drug reimbursment

Nintedanib and pirfenidone

5.9

17.0

N05AH04

ATC

quetiapine; oral

1.6

17.0

393

2526

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.8

16.9

136

R60.0

ICD-10 Finland

Localized oedema

1.7

16.7

341

2121

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

16.6

251

1432

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

16.6

271

1583

P01AB01

ATC

metronidazole; oral, rectal

1.4

16.5

914

7048

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.9

16.5

275

F10.24

ICD-10 Finland

Alcohol depence active use

3.9

16.4

125

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

16.4

315

C01AA05

ATC

digoxin; systemic

1.7

16.4

329

2036

J01DA01

ATC

[U] cefalexin

1.4

16.4

1616

13717

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.5

16.3

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.3

16.3

183

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

16.2

116

503

J01FA10

ATC

azithromycin; systemic

1.4

16.2

1169

9430

R50.9

ICD-10 Finland

Fever, unspecified

1.6

16.1

414

2726

A01AB04

ATC

amphotericin B; local oral

2.3

16.1

127

574

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

16.1

220

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

24.6

16.0

N06AA12

ATC

doxepin; systemic

2.1

15.8

143

684

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

4.0

15.7

111

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

15.7

234

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

15.6

395

2590

XQ800

NOMESCO Finland

Prick test

2.4

15.6

106

449

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

15.6

145

701

J01DB01

ATC

cefalexin; oral

1.4

15.5

2176

19473

L04AD01

ATC

ciclosporin; systemic

3.4

15.5

159

N06AX21

ATC

duloxetine; oral

1.8

15.4

239

1376

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

15.3

234

1341

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

15.3

123

561

Z57.2

ICD-10 Finland

Occupational exposure to dust

11.3

15.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

15.2

624

4541

B01AF02

ATC

apixaban; oral

1.6

15.2

409

2722

R99

ICPC

Respiratory disease other

3.2

15.2

181

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

15.1

507

7022

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

15.1

145

710

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

15.0

133

631

N02BE01

ATC

paracetamol; systemic, rectal

1.4

14.9

2432

22242

L01CA04

ATC

vinorelbine; systemic

4.5

14.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

14.9

178

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

14.9

210

1173

N05AF03

ATC

chlorprothixene; systemic

3.0

14.9

225

S22.3

ICD-10 Finland

Fracture of rib

1.8

14.9

216

1218

L28

ICPC

Limited function/disability (L)

1.5

14.9

511

3588

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

14.7

969

7672

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

14.6

389

2581

G47.3

ICD-10 Finland

Sleep apnoea

1.5

14.6

550

3933

E0000UV, ,

ATC

1.4

14.5

974

7731

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

14.4

186

1010

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

14.3

863

6724

R53

ICD-10 Finland

Malaise and fatigue

1.5

14.2

589

4290

R84

ICPC

Malignant neoplasm bronchus/lung

6.2

14.2

J01DA06

ATC

[U] cefuroxime

1.6

14.1

323

2068

A04

ICPC

Weakness/tiredness general

1.6

14.0

363

2391

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.0

14.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

14.0

354

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

13.9

115

530

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

13.9

116

538

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

13.8

177

960

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

13.8

307

1951

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

13.8

219

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

13.7

145

735

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

13.7

394

2658

SPAT1104

SPAT

Monitoring of emergency patient

1.9

13.7

189

1049

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

13.7

867

6802

R13

ICD-10 Finland

Dysphagia

1.8

13.7

193

1079

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.7

13.6

265

C08DA01

ATC

verapamil; systemic

2.1

13.6

123

589

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.7

13.6

119

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

13.5

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.5

13.5

354

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

16.3

13.4

RS221, ,

NOMESCO Finland

3.7

13.3

111

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.9

13.3

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

13.3

165

R01AD09

ATC

mometasone; nasal

1.4

13.3

884

6986

F32

ICD-10 Finland

Depressive episode

2.4

13.2

401

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.7

13.1

108

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

13.1

385

2611

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

13.1

210

1221

XJC10

NOMESCO Finland

Oesophageal pH monitoring

5.9

13.1

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

5.9

13.1

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

13.0

121

585

UJF32

NOMESCO Finland

Coloscopy

1.4

13.0

711

5434

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.8

13.0

104

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

12.9

147

765

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

12.9

392

2675

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

3.0

12.9

184

N06AB03

ATC

fluoxetine; oral

1.7

12.8

262

1627

356

Kela drug reimbursment

Nintedanib and pirfenidone

5.4

12.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

12.7

217

1283

J01DA09

ATC

[U] cefadroxil

1.4

12.7

620

4646

R04

ICPC

Breathing problem other

2.3

12.7

396

N06AX03

ATC

mianserin; oral

2.1

12.6

123

607

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

12.5

221

1321

SPD00

NOMESCO Finland

Mucosa borne complete denture

3.4

12.5

126

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

12.5

131

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

5.6

12.4

EBA00

NOMESCO Finland

Extraction of tooth

1.4

12.4

838

6624

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.7

12.3

A02BA03

ATC

famotidine; systemic

2.1

12.2

122

607

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

3.8

12.2

A46

ICD-10 Finland

Erysipelas

1.5

12.1

410

2861

R07.3

ICD-10 Finland

Other chest pain

1.6

12.1

258

1621

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.9

12.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

12.0

259

1631

P76

ICPC

Depressive disorder

2.2

12.0

457

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

3.9

12.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

11.9

134

695

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

11.8

396

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

5.9

11.8

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

10.5

11.7

F34.1

ICD-10 Finland

Dysthymia

2.6

11.7

274

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

11.7

506

3702

L04AD02

ATC

tacrolimus; systemic

4.3

11.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

11.7

742

5799

R52.2

ICD-10 Finland

Other chronic pain

2.3

11.7

360

PD5AD

NOMESCO Finland

CT of aorta

2.4

11.7

317

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.8

11.6

K08.3

ICD-10 Finland

Retained dental root

1.7

11.6

205

1224

GDB00

NOMESCO Finland

Resection of bullae of lung

65.2

11.6

Z72.1

ICD-10 Finland

Alcohol use

3.5

11.6

108

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

11.5

291

1904

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

11.5

277

1793

RS230, ,

NOMESCO Finland

5.7

11.5

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

11.5

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.4

11.4

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.7

11.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.4

207

1246

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.2

11.4

139

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

11.4

430

3068

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

11.4

146

793

N05AA01

ATC

chlorpromazine; systemic, rectal

3.3

11.3

129

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.8

11.3

209

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

11.3

149

815

SPAT1260

SPAT

Consultation of another employee

1.5

11.3

429

3061

W19

ICD-10 Finland

Unspecified fall

1.6

11.3

255

1625

N05BA12

ATC

alprazolam; oral

1.7

11.3

229

1421

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

11.3

347

R04.0

ICD-10 Finland

Epistaxis

1.6

11.2

240

1508

A01AB10

ATC

natamycin; local oral

2.5

11.2

268

R01

ICPC

Pain respiratory system

3.4

11.2

115

R51.80

ICD-10 Finland

Headache

1.6

11.2

279

1819

ZXA05

NOMESCO Finland

Left side

1.4

11.2

671

5190

RK320, ,

NOMESCO Finland

4.0

11.2

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

4.6

11.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

11.2

388

2721

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

11.2

399

WZC30

NOMESCO Finland

Teaching

1.5

11.1

389

2731

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

11.1

167

953

ZXD35

NOMESCO Finland

Usual procedure

2.2

11.1

407

EBA30

NOMESCO Finland

Extraction of root of tooth

1.8

11.1

168

961

D07AC01

ATC

betamethasone; topical

1.3

11.0

886

7170

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.0

10.9

N05BE01

ATC

buspirone; oral

2.4

10.8

291

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

3.9

10.8

A08

ICPC

Swelling

1.9

10.8

134

719

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

10.8

477

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

3.3

10.8

123

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.8

1096

9152

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

10.8

716

5627

SPE01

NOMESCO Finland

Mucosa-supported partial denture

2.5

10.7

262

XA421

NOMESCO Finland

Nocturnal polygraphy

9.6

10.7

P01BA02

ATC

hydroxychloroquine; oral

1.8

10.7

174

1015

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

10.7

945

7738

M54.5

ICD-10 Finland

Low back pain

1.3

10.7

749

5930

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

10.7

268

1750

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

21.5

10.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

10.6

J01DA08

ATC

[U] cefaclor

1.8

10.6

163

936

C09AA05

ATC

ramipril; oral

1.3

10.6

806

6460

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.2

10.6

389

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

3.1

10.6

135

R33

ICD-10 Finland

Retention of urine

1.5

10.5

317

2158

M05BA07

ATC

risedronic acid; oral

2.5

10.5

277

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

9.2

10.5

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

10.5

203

1244

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

10.4

146

815

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

10.4

248

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

10.4

N05AB01

ATC

dixyrazine; systemic

3.2

10.4

131

T08

ICPC

Weight loss

2.8

10.4

174

R01AD12

ATC

fluticasone furoate; nasal

1.4

10.4

522

3919

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

10.4

159

913

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

3.6

10.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

10.3

191

WX402

NOMESCO Finland

General anaesthesia

1.4

10.3

459

3371

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.3

495

3685

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

10.3

361

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.3

10.3

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

10.3

433

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

10.2

154

879

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

10.2

151

857

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

10.2

458

3371

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

3.2

10.1

128

R06AX27

ATC

desloratadine; oral

1.4

10.1

440

3219

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.1

934

7685

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

10.1

417

E87.6

ICD-10 Finland

Hypokalaemia

2.1

10.0

437

L57.0

ICD-10 Finland

Actinic keratosis

0.6

10.0

142

2420

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.3

10.0

109

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

10.0

199

1229

J93

ICD-10 Finland

Pneumothorax

40.2

10.0

L04AX01

ATC

azathioprine; systemic

2.1

9.9

459

XX2RW, ,

NOMESCO Finland

3.6

9.9

N05BA02

ATC

chlordiazepoxide; systemic

2.4

9.9

291

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.1

9.9

125

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

9.9

120

SBA00

NOMESCO Finland

Microbiological examinations

2.5

9.9

237

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.4

9.8

105

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

12.2

9.8

L30.3

ICD-10 Finland

Infective dermatitis

2.2

9.8

382

RK250, ,

NOMESCO Finland

4.9

9.8

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

9.8

218

1385

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.7

9.8

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

9.7

114

601

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

9.7

188

1152

WX872

NOMESCO Finland

Intensive care

1.8

9.7

156

908

R06.4

ICD-10 Finland

Hyperventilation

3.4

9.7

101

L04AA13

ATC

[U] leflunomide

2.6

9.7

215

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

9.7

211

1332

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

2.9

9.7

148

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

9.6

141

799

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

9.6

436

3212

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.8

9.6

165

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

9.6

137

771

E000003, ,

ATC

2.0

9.6

466

R79

ICPC

Chronic bronchitis

15.1

9.5

S27.0

ICD-10 Finland

Traumatic pneumothorax

3.5

9.5

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

9.5

266

RS220, ,

NOMESCO Finland

3.3

9.4

103

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

9.4

279

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

9.4

292

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

+∞

9.4

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

9.4

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

+∞

9.4

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

5.2

9.4

ZXA10

NOMESCO Finland

Bilateral

1.4

9.3

464

3472

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.8

9.3

162

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

9.3

107

561

B01AB05

ATC

enoxaparin; parenteral

1.3

9.3

799

6496

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

9.3

288

1973

V03AA01, ,

ATC

2.6

9.3

191

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

9.5

9.3

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.9

9.2

120

655

N05AL01

ATC

sulpiride; systemic

3.1

9.2

125

P15

ICPC

Chronic alcohol abuse

2.3

9.2

288

K29.8

ICD-10 Finland

Duodenitis

3.5

9.2

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.2

9.2

110

B01AA03

ATC

warfarin; systemic

1.3

9.1

692

5526

SPAT1301

SPAT

No procedures

1.3

9.1

793

6454

ZX120

NOMESCO Finland

Intravenous

1.6

9.1

240

1585

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

4.3

9.1

B37.08

ICD-10 Finland

Other candidal stomatitis

4.3

9.1

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

9.1

159

TGA30

NOMESCO Finland

Thoracocentesis

3.5

9.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

9.0

363

2615

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

15.6

9.0

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

36.8

9.0

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

36.8

9.0

30041

ICD-8 Finland

Neuroses, Depressiva

2.9

9.0

143

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.3

9.0

298

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

9.0

333

2364

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

8.9

129

728

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

8.9

125

699

E000001, ,

ATC

1.4

8.9

430

3200

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

8.9

377

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

8.9

299

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.9

8.9

144

N02BF02

ATC

pregabalin; oral

1.9

8.9

118

649

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

8.9

151

894

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

8.9

217

1410

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

8.9

371

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

8.9

391

I70

ICD-10 Finland

Atherosclerosis

4.3

8.9

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.3

8.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

8.8

169

1033

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

8.8

275

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.8

512

3928

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

8.8

153

912

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

8.8

263

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

10.7

8.8

T74.1

ICD-10 Finland

Physical abuse

3.4

8.7

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

8.7

475

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

8.7

177

1099

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

8.7

123

690

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

8.7

180

1123

J01GB01

ATC

tobramycin; inhalant, parenteral

50.1

8.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

8.7

163

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

8.6

107

576

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.0

8.6

125

SPE90

NOMESCO Finland

Other partial denture

2.2

8.6

310

SPAT1255

SPAT

Intravenous administration of medicine

1.6

8.6

179

1119

5BA08, ,

NOMESCO Finland

4.6

8.6

AP2

Catheterization of the right side of the heart

4.8

8.6

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

8.2

8.6

XF402

NOMESCO Finland

ECG with work load test

1.5

8.6

288

2005

R50

ICPC

Respiratory, Medication/prescr/renewal

16.3

8.5

L95

ICPC

Osteoporosis

2.1

8.5

364

E88.9

ICD-10 Finland

Metabolic disorder, unspecified

90.3

8.4

3A006, ,

NOMESCO Finland

90.3

8.4

G44.2

ICD-10 Finland

Tension-type headache

1.5

8.4

233

1558

ZXA00

NOMESCO Finland

Right side

1.3

8.4

698

5641

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

3.1

8.4

106

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.6

8.4

172

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.9

8.4

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.4

360

I20.09

ICD-10 Finland

Unstable angina

1.6

8.3

190

1214

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

8.3

173

1081

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

8.5

8.3

WX726

NOMESCO Finland

High-flow oxygen therapy

10.8

8.3

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

8.3

172

1075

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

3.2

8.2

102

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.8

8.2

112

622

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

14.5

8.2

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.0

8.2

113

H02AB09

ATC

hydrocortisone; systemic

2.5

8.1

210

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

8.1

198

EB4VA, ,

NOMESCO Finland

0.4

8.1

1147

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.3

8.1

241

M79.6

ICD-10 Finland

Pain in limb

1.3

8.1

905

7588

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

8.1

186

1191

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

33.4

8.1

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

8.1

M79.7

ICD-10 Finland

Fibromyalgia

2.6

8.1

181

N06AB06

ATC

sertraline; oral

1.6

8.1

194

1256

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.1

419

3155

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.0

8.1

399

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.0

8.1

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.8

8.0

136

RS222, ,

NOMESCO Finland

3.0

8.0

109

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

8.0

108

598

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

3.1

8.0

104

WVA20

NOMESCO Finland

Medicine administration

2.2

7.9

315

D75.1

ICD-10 Finland

Secondary polycythaemia

3.9

7.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

7.9

111

623

XX4BW, ,

NOMESCO Finland

13.0

7.9

N05BB01

ATC

hydroxyzine; systemic

1.7

7.9

132

780

R74

ICPC

Upper respiratory infection acute

1.4

7.8

457

3504

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

7.8

217

1451

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.1

7.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

7.8

659

5329

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

7.8

575

4564

P16

ICPC

Acute alcohol abuse

2.8

7.8

138

DQA10

NOMESCO Finland

Biopsy of larynx

3.8

7.8

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

7.8

432

GX1D5

NOMESCO Finland

Flow volume spirometry

9.4

7.8

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.7

7.7

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

3.7

7.7

B37.0

ICD-10 Finland

Candidal stomatitis

3.7

7.7

M05BX04

ATC

denosumab; parenteral

1.7

7.7

142

860

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

7.7

125

731

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

7.7

155

961

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

15.0

7.7

A01

ICPC

Pain general/multiple sites

1.6

7.7

196

1286

N05AH02

ATC

clozapine; systemic

2.9

7.7

117

R01AD58

ATC

fluticasone, combinations; nasal

1.4

7.7

353

2603

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.5

7.7

1322

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

4.3

7.7

R43

ICPC

Respiratory, Other diagnostic procedure

4.3

7.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

7.7

419

3180

PDH54

NOMESCO Finland

Bypass from aorta to bilateral femoral arteries

7.4

7.7

WX250

NOMESCO Finland

Intercostal blockade

7.4

7.7

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.5

7.7

180

RS123, ,

NOMESCO Finland

18.4

7.6

S97

ICPC

Chronic ulcer skin

1.6

7.6

168

1067

H05AA02

ATC

teriparatide; parenteral

6.7

7.6

R49.08

ICD-10 Finland

Other specified dysphonia

2.5

7.6

175

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

7.5

139

843

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

7.5

212

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.2

7.5

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

2.7

7.5

141

N06AA10

ATC

nortriptyline; systemic

2.6

7.5

170

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

7.5

1002

C34

ICD-10 Finland

Malignant neoplasm of bronchus and lung

7.1

7.5

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.4

297

2136

R52.0

ICD-10 Finland

Acute pain

2.1

7.4

316

PE1AT

NOMESCO Finland

Femoral artery PTA

2.5

7.4

171

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

7.4

317

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

7.4

271

N05AH03

ATC

olanzapine; systemic

1.8

7.3

114

659

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

7.3

895

7566

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

7.3

130

780

207

Kela drug reimbursment

Chronic arrhythmias

1.3

7.3

484

3779

R05CB03

ATC

carbocisteine; oral

2.3

7.3

246

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

7.3

123

727

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

7.3

49200, ,

ICD-8 Finland

+∞

7.3

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

7.3

209

N06DX01

ATC

memantine; oral

0.6

7.3

110

1844

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

7.3

478

N19

ICD-10 Finland

Unspecified kidney failure

1.7

7.3

122

721

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.7

7.3

132

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.2

7.3

J01DC02

ATC

cefuroxime; systemic

1.8

7.2

551

318

Kela drug reimbursment

Teriparatide

6.2

7.2

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

7.2

159

1009

R01AD08

ATC

fluticasone; nasal

1.3

7.2

503

3959

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.7

7.2

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.2

7.2

281

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

30.1

7.1

GAC40

NOMESCO Finland

Pleurodesis with decortication

30.1

7.1

XX4AW, ,

NOMESCO Finland

20.1

7.1

WX110, ,

SPAT

1.7

7.1

113

658

SPF03

NOMESCO Finland

Impression for dental prosthesis repair, demanding

3.2

7.1

Z71.8

ICD-10 Finland

Other specified counselling

1.3

7.1

609

4928

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.4

7.1

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

4.1

7.1

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

4.1

7.1

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

7.1

398

L17

ICPC

Foot/toe symptom/complaint

1.3

7.1

646

5272

R10.0

ICD-10 Finland

Acute abdomen

2.0

7.0

357

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

7.0

148

929

ZY010

NOMESCO Finland

Hospital outpatient

1.9

7.0

434

N05AC02

ATC

thioridazine; oral

2.4

7.0

194

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.6

7.0

152

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.9

7.0

406

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

7.0

470

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

7.0

164

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

7.0

167

1081

SPAT1097

SPAT

Recording of ECG

1.4

7.0

378

2864

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.0

231

1604

N05AF05

ATC

zuclopenthixol; systemic

3.4

7.0

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.4

7.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

7.0

947

8097

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

6.3

6.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

6.9

292

GAA31

NOMESCO Finland

Thoracoscopy

5.8

6.9

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

7.5

6.9

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.0

6.9

L04AX03

ATC

methotrexate; systemic

1.5

6.9

192

1287

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

6.9

122

733

N17.8

ICD-10 Finland

Other acute renal failure

2.6

6.9

142

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.9

338

2522

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

6.9

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.4

6.8

178

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

6.8

755

6301

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.5

6.8

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.1

6.8

300

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

8.3

6.8

FM1DE, ,

SPAT

4.1

6.8

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.0

6.8

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

3.8

6.8

J94.8

ICD-10 Finland

Other specified pleural conditions

2.2

6.8

248

OAA67, ,

SPAT

0.5

6.8

1084

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

9.3

6.8

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.6

6.8

149

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

2.3

6.8

210

XF622

NOMESCO Finland

Measurement of minute volume of heart

6.1

6.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

6.8

408

3143

A15.2

ICD-10 Finland

Tuberculosis of lung, confirmed histologically

40.1

6.8

K55.8

ICD-10 Finland

Other vascular disorders of intestine

3.6

6.7

5841

FHL

Trocar rhostomy

16.7

6.7

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.7

6.7

132

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.9

6.7

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

6.7

181

1205

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.2

6.7

256

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.6

6.7

144

ZPB22

NOMESCO Finland

Autograft of vein

3.2

6.7

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

3.4

6.7

P03

ICPC

Feeling depressed

1.7

6.7

117

701

SAA04

NOMESCO Finland

Special examination of mouth

1.8

6.6

103

596

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

6.6

133

R03CC02

ATC

salbutamol; systemic

2.3

6.6

212

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.1

6.6

277

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

6.6

1636

14855

L04AA01

ATC

[U] ciclosporin

2.8

6.6

111

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

6.6

232

1632

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

6.6

278

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

3.5

6.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

6.5

532

G44.0

ICD-10 Finland

Cluster headache syndrome

3.4

6.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

6.5

224

1566

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

2.8

6.5

117

R03BC01

ATC

cromoglicic acid; inhalant

3.8

6.5

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.7

6.5

123

752

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

6.5

368

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.8

6.5

541

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

6.5

348

4526

64190

ICD-8 Finland

Artificial termination of pregnancy performed on the basis of another legal reason, Humanitarian reason

3.5

6.4

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.5

6.4

159

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

6.4

210

1455

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

6.4

132

825

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

7.4

6.4

T23.1

ICD-10 Finland

Burn of first degree of wrist and hand

7.4

6.4

R64

ICD-10 Finland

Cachexia

7.4

6.4

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.4

208

1440

A02BX05

ATC

bismuth subcitrate; oral

2.2

6.4

222

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.0

6.4

315

S82

ICPC

Naevus/mole

0.6

6.4

140

2143

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

3.7

6.4

N06AG02

ATC

moclobemide; oral

1.8

6.3

493

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

4.1

6.3

GDB10

NOMESCO Finland

Wedge resection of lung

8.2

6.3

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.7

6.3

186

2681

L02

ICPC

Back symptom/complaint

1.5

6.3

166

1099

D07AC13

ATC

mometasone; topical

1.3

6.3

657

5439

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.8

6.3

108

ZX050

NOMESCO Finland

Stereotactic radiotherapy

2.9

6.3

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

6.3

671

7990

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.5

6.3

I50.1

ICD-10 Finland

Left ventricular failure

1.5

6.3

164

1084

SPAT1251

SPAT

Organisation of medication

1.8

6.3

539

L01XE31

ATC

[U] nintedanib

9.3

6.3

1CX01, ,

NOMESCO Finland

9.3

6.3

1240

FHL

Bronchoscopy

2.6

6.3

137

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.3

6.3

XG420

NOMESCO Finland

Time-volume spirometry

18.0

6.3

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

6.3

1514

H26.3

ICD-10 Finland

Drug-induced cataract

3.8

6.3

PA6AD

NOMESCO Finland

CT of neck arteries

1.9

6.2

395

D14.3

ICD-10 Finland

Benign neoplasm: Bronchus and lung

7.0

6.2

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

6.2

298

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

6.2

305

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

2.7

6.2

115

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

4.0

6.2

SPA47

NOMESCO Finland

Precision impression for denture

2.0

6.2

347

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.1

6.2

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.1

6.2

G20

ICD-10 Finland

Parkinson disease

0.4

6.1

705

PD7ZT

NOMESCO Finland

Stent grafting of abdominal aorta

3.2

6.1

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

6.1

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

6.1

397

K20

ICD-10 Finland

Oesophagitis

2.3

6.1

194

K41.3

ICD-10 Finland

Unilateral or unspecified femoral hernia, with obstruction, without gangrene

7.7

6.1

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

0.4

6.1

646

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

0.4

6.1

631

D07XC01

ATC

betamethasone; topical

1.4

6.1

297

2212

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

6.1

264

3553

J02AC03

ATC

voriconazole; systemic

8.6

6.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.0

197

1365

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

6.0

568

J02AC01

ATC

fluconazole; systemic

1.3

6.0

635

5264

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023419) Bacteria identified in Sputum by Culture

314

194

17.91

307.65

3.2

1.6

—

(4200892) Spirometry reversibility

587

1019

6.88

307.65

1.8

1.2

—

(3019060) Gas panel - Arterial blood

678

1583

5.21

278.99

4.6

4.9

—

(3003396) Base excess in Arterial blood by calculation

915

2860

4.13

257.30

8.3

7.0

1.67

0.72

mmol/l

8.40

756

2245

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

909

2856

4.10

253.35

8.3

7.0

5.16

5.00

kpa

4.14

863

2720

(3027801) Oxygen [Partial pressure] in Arterial blood

908

2855

4.09

252.74

8.3

7.0

9.41

12.43

kpa

75.99

863

2719

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

424

721

6.66

243.90

3.8

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

377

630

6.68

219.94

1.4

1.1

240.11

202.03

u/ml

0.46

350

565

(3000492) Spirometry study

543

1305

4.84

212.49

2.1

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

813

2711

3.72

203.12

2.7

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

812

2720

3.70

201.31

2.6

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1019

4011

3.30

194.79

2.7

1.7

—

(3016502) Oxygen saturation in Arterial blood

782

2617

3.67

193.39

8.5

7.3

92.39

95.66

22.03

746

2516

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

235

264

9.55

192.73

1.1

1.51

1.56

g/l

0.74

219

237

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

519

1302

4.59

191.51

9.1

24.91

23.92

mmol/l

7.59

502

1258

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

237

9.53

174.30

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

1896

11086

2.85

169.52

8.5

5.7

0.20

0.19

e9/l

0.90

1668

9510

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

183

176

10.99

167.66

4.4

2.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1781

10141

2.80

166.65

9.0

6.2

—

(3006315) Basophils [#/volume] in Blood

1851

10792

2.80

164.59

8.1

5.5

0.04

e9/l

6.44

1612

9138

(3001604) Monocytes [#/volume] in Blood

1844

10750

2.79

163.67

8.1

5.5

0.70

0.61

e9/l

31.64

1605

9107

(3019198) Lymphocytes [#/volume] in Blood

1857

11014

2.73

156.71

8.1

5.6

1.84

1.89

e9/l

0.52

1643

9524

(3023368) Bacteria identified in Blood by Culture

1396

7224

2.71

154.60

5.9

4.2

—

(3022096) Basophils/100 leukocytes in Blood

1718

9857

2.68

154.16

8.3

5.8

0.59

0.66

4.96

1651

9080

(3019069) Monocytes/100 leukocytes in Blood

1755

10208

2.67

152.61

8.7

6.1

8.79

8.99

1.73

1686

9427

(3006504) Eosinophils/100 leukocytes in Blood

1749

10168

2.67

152.05

8.4

5.8

2.50

2.84

7.22

1680

9379

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

276

492

6.06

149.59

2.1

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1766

10411

2.63

147.63

8.5

6.0

23.00

26.61

36.67

1698

9628

(3018010) Neutrophils/100 leukocytes in Blood

1732

10246

2.58

141.67

8.3

5.7

61.67

58.04

28.17

1666

9465

(3042631) Mycobacterium sp identified in Specimen

200

277

7.65

137.69

3.1

2.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

657

2422

3.18

134.60

9.5

7.6

128.41

120.21

g/l

16.02

637

2357

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

454

1444

3.51

117.21

9.9

7.0

25.68

24.41

mmol/l

6.53

448

1431

(3013650) Neutrophils [#/volume] in Blood by Automated count

1931

12721

2.39

114.71

11.5

8.8

5.11

4.22

e9/l

37.41

1715

10951

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

244

517

5.04

108.76

2.2

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1368

7919

2.31

108.16

4.0

3.0

1792.44

1856.18

ng/l

0.20

1232

6832

(3006184) Hemoglobin [Mass/volume] in Capillary blood

236

497

5.06

105.90

2.5

2.1

132.58

128.69

g/l

1.00

127

378

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

249

549

4.85

105.82

2.1

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

361

5.82

105.35

2.2

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

21.60

104.48

1.4

1.1

1.74

1.60

u/ml

0.04

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

902

4423

2.47

103.43

2.2

1.7

1.37

1.56

mg/l

0.85

743

3444

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

11.55

98.81

4.2

3.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

447

1571

3.16

97.21

5.3

3.4

5.30

5.05

kpa

5.63

438

1465

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1688

10971

2.19

96.90

8.8

6.0

1.20

1.21

mmol/l

7.19

1554

9895

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

431

1488

3.21

96.56

5.1

3.4

2.32

1.53

mmol/l

3.84

341

1043

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

295

6.04

94.14

2.1

1.4

—

(3009343) pH of Capillary blood

437

1547

3.13

93.69

5.2

3.4

7.41

0.07

181

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

195

399

5.15

90.27

2.1

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

213

474

4.75

89.28

1.7

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

213

474

4.75

89.28

1.7

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

545

2236

2.75

88.96

9.1

6.6

1.41

1.43

mmol/l

0.11

528

2169

(1616796) Gas panel - Central venous blood

223

522

4.53

87.77

5.5

3.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1771

12039

2.11

86.63

9.0

6.9

1.20

1.21

mmol/l

6.89

1492

10129

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

168

317

5.55

85.09

2.1

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

397

1403

3.10

84.98

11.5

9.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

121

167

7.50

83.23

2.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

148

254

6.07

82.81

2.5

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

426

1590

2.95

82.68

9.0

6.8

24.66

24.27

mmol/l

1.14

404

1511

(3018418) pH of Serum or Plasma

1187

7056

2.11

81.88

4.6

4.1

7.41

7.40

1.48

264

1362

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1782

12333

2.06

80.65

7.7

6.4

11.24

12.79

umol/l

6.18

1705

11694

(3000991) Gas panel - Venous blood

511

2140

2.66

79.46

10.7

7.7

—

(3002032) Base excess in Venous blood by calculation

548

2391

2.57

78.29

4.6

3.7

2.65

1.65

mmol/l

5.96

462

1977

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

165

332

5.19

77.75

1.7

1.4

—

(3010421) pH of Blood

234

628

3.95

76.63

7.5

4.2

7.42

0.71

214

566

(3027315) Oxygen [Partial pressure] in Blood

215

543

4.18

76.52

7.7

4.4

7.74

8.48

kpa

9.31

210

528

(3021447) Carbon dioxide [Partial pressure] in Venous blood

544

2392

2.55

76.32

4.7

3.7

6.09

5.73

kpa

8.67

528

2310

(3012095) Magnesium [Moles/volume] in Serum or Plasma

763

3908

2.27

75.84

5.2

3.2

0.80

0.82

mmol/l

2.69

718

3651

(3012501) Base excess in Blood by calculation

213

540

4.16

75.40

7.7

4.3

3.02

2.48

mmol/l

1.40

156

343

(3013290) Carbon dioxide [Partial pressure] in Blood

213

540

4.16

75.40

7.7

4.3

5.12

4.91

kpa

2.13

208

526

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

293

5.37

74.09

1.7

1.4

—

(3021901) Oxygen saturation in Capillary blood

188

453

4.35

71.12

4.0

2.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1746

12377

1.95

69.35

19.5

18.7

1.32

1.39

inr

1.89

520

3488

(3037522) Nuclear Ab [Titer] in Serum

525

2432

2.40

64.97

1.4

1.3

528.16

472.07

titre

0.25

114

535

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

158

359

4.58

64.34

2.2

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

158

359

4.58

64.34

2.2

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1527

10522

1.90

64.25

5.7

4.9

33.27

34.83

g/l

18.92

1429

9717

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

321

1190

2.89

62.36

4.4

3.9

24.77

23.82

mmol/l

4.86

315

1153

(3009445) Proteinase 3 Ab [Units/volume] in Serum

276

944

3.11

61.84

1.4

1.6

2.96

25.19

u/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

376

1527

2.67

61.30

3.0

2.8

10.30

10.80

g/l

1.22

358

1371

(40767503) Oxygen content in Capillary blood by calculation

191

522

3.83

60.77

3.8

2.3

15.47

16.15

1.12

107

256

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

120

231

5.36

59.34

2.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

120

231

5.36

59.34

2.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

837

4904

1.97

55.83

5.8

3.8

727.78

725.35

ng/l

0.00

758

4183

(3013826) Glucose [Moles/volume] in Serum or Plasma

1879

14218

1.83

54.92

8.5

4.8

6.67

6.92

mmol/l

6.74

1813

13398

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

351

1461

2.58

54.16

2.0

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

366

1559

2.53

53.80

2.4

1.6

—

(3019977) pH of Arterial blood

132

6.67

53.62

2.6

2.4

7.42

0.05

(3022313) Gas panel - Capillary blood

293

1131

2.76

52.48

5.6

3.5

—

(3021589) Normoblasts [#/volume] in Blood

1388

9722

1.78

51.43

15.1

9.9

0.00

e9/l

0.52

1113

7897

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1066

6938

1.82

50.34

4.1

3.2

35.34

39.55

u/l

0.47

992

6551

(3028026) IgM [Mass/volume] in Serum or Plasma

301

1205

2.66

50.13

1.9

2.0

1.17

1.38

g/l

1.29

276

1073

(3024354) Oxygen [Partial pressure] in Venous blood

417

1970

2.29

48.39

4.0

3.0

4.19

4.50

kpa

2.72

399

1899

(3042936) Bacteria identified in Isolate by Culture

612

3357

2.03

48.38

2.4

2.0

—

(3000494) Fungus identified in Specimen by Culture

489

2478

2.16

47.71

2.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

195

5.21

47.70

1.8

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

150

412

3.78

47.30

3.3

3.7

59.54

58.11

0.63

150

412

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

17.47

46.30

3.1

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

462

2318

2.17

46.13

3.9

2.9

219.49

252.49

ng/l

0.74

428

2117

(3002582) Erythrocytes [#/volume] in Urine

1133

7658

1.76

46.10

4.7

3.4

136.56

106.41

e6/l

0.15

902

5990

(3030905) Polymorphonuclear cells [#/volume] in Blood

145

396

3.79

46.09

3.0

3.3

4.91

4.29

e9/l

1.91

145

396

(46235355) HIV 1 and 2 tests - Meaningful Use set

452

2249

2.18

46.09

1.5

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1091

7299

1.77

45.97

2.9

2.5

59.35

71.09

u/l

0.49

1016

6711

(3030467) Casts [#/volume] in Urine by Automated count

1046

6942

1.77

45.14

4.5

3.3

0.59

0.46

e6/l

0.87

831

5389

(3033658) Prothrombin time (PT) actual/Normal

931

5976

1.80

45.00

6.1

3.9

84.41

83.79

0.32

909

5840

(3020891) Body temperature

256

997

2.71

44.90

5.9

4.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

152

443

3.56

43.89

1.5

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

391

1876

2.24

43.48

4.7

4.1

0.88

0.93

0.20

179

710

(3025159) Blasts/100 leukocytes in Blood

358

1656

2.31

43.43

4.7

4.2

0.06

0.18

1.77

141

509

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

131

6.00

43.39

1.9

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1340

9606

1.70

43.31

5.9

3.8

104.57

124.35

ng/l

0.09

1088

7390

(3037692) Legionella sp identified in Specimen by Organism specific culture

8.28

43.21

2.4

1.3

—

(36304419) Bacteria [Presence] in Urine

1005

6664

1.75

43.06

4.5

3.3

—

(3018095) Leukocytes [#/volume] in Urine

1229

8620

1.71

42.98

5.4

3.9

90.72

113.34

e6/l

0.54

943

6359

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

133

5.91

42.73

1.9

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

682

4037

1.89

42.48

2.2

2.0

30.65

30.07

1.45

659

3911

(40758558) Short blood count panel - Blood

870

5562

1.79

42.12

8.5

6.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2194

18031

1.76

41.87

10.5

7.6

82.48

81.18

u/l

0.58

2104

16869

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

5.37

41.54

1.8

1.4

—

(3047181) Lactate [Moles/volume] in Blood

212

785

2.83

40.89

7.2

6.1

1.28

1.36

mmol/l

0.65

189

694

(3020779) Urea [Moles/volume] in Serum or Plasma

460

2437

2.04

39.37

8.6

7.1

10.57

11.34

mmol/l

1.28

438

2305

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

268

1143

2.47

38.88

2.1

1.9

1.07

2.96

ug/l

2.42

241

998

(3002179) Metamyelocytes/100 leukocytes in Blood

353

1702

2.21

38.58

4.4

4.0

0.50

0.68

1.39

145

611

(3021440) Promyelocytes/100 leukocytes in Blood

362

1774

2.18

37.96

4.7

4.2

0.17

0.11

0.41

149

610

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

123

345

3.67

37.60

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

355

1747

2.17

36.79

2.4

2.2

347.27

385.37

nmol/l

2.97

329

1578

(3026782) Osmolality of Urine

801

5168

1.74

36.73

3.6

3.0

532.22

562.56

mosm/kgh2o

4.25

710

4448

(3013707) Erythrocyte sedimentation rate by Westergren method

2014

16430

1.65

36.69

6.2

3.9

17.31

13.32

mm/h

16.90

1895

14947

(3003458) Phosphate [Moles/volume] in Serum or Plasma

568

3332

1.86

35.72

6.1

5.9

1.05

1.03

mmol/l

0.45

528

3074

(3000850) Epithelial cells [#/volume] in Urine

820

5364

1.72

35.61

3.4

2.7

4.63

4.06

e6/l

0.73

751

4822

(3015171) Extractable nuclear Ab [Units/volume] in Serum

174

629

2.87

35.04

1.2

0.50

0.72

u/ml

0.28

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

194

749

2.70

34.48

1.7

1.5

311.67

253.17

titre

0.10

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

345

1752

2.09

32.80

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

421

2297

1.96

32.78

2.1

2.2

0.20

g/l

0.08

385

2127

(3022948) Iron [Moles/volume] in Serum or Plasma

634

3937

1.77

32.74

2.6

2.5

11.21

12.71

umol/l

4.65

597

3669

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

204

829

2.56

32.68

1.6

1.8

38.86

37.90

u/l

0.22

180

698

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

641

4001

1.76

32.49

4.3

3.2

2.61

1.42

e6/l

2.94

347

2306

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

239

1049

2.39

32.43

6.2

5.3

2.10

1.60

6.05

222

981

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

210

885

2.47

31.14

2.7

2.2

464.12

600.74

ug/l

0.41

193

840

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

225

979

2.40

31.11

6.1

3.7

24.87

24.60

mmol/l

0.70

215

884

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

511

3018

1.83

31.07

1.3

1.2

55.06

37.69

iu/ml

0.89

170

919

(3004789) Transferrin [Mass/volume] in Serum or Plasma

593

3662

1.77

31.04

2.6

2.5

2.24

2.23

g/l

0.13

559

3390

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1046

7492

1.60

31.01

3.1

2.1

254.54

218.54

u/l

0.20

982

7005

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

3.98

30.52

1.8

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

240

3.88

30.42

1.8

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

520

3112

1.81

30.20

3.6

4.3

254.71

250.29

u/l

0.19

494

2915

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.97

29.95

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

659

4236

1.71

29.75

4.0

3.0

1.25

1.08

e6/l

0.59

368

2514

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

455

2625

1.86

29.73

2.5

2.8

7.88

9.99

umol/l

1.44

394

2329

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

566

3490

1.76

29.65

2.7

2.6

20.75

22.97

2.27

486

2991

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

154

574

2.77

29.27

2.6

2.2

205.76

200.83

0.26

148

545

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

383

2099

1.94

29.26

3.1

2.3

31.76

39.35

u/l

1.62

335

1792

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

162

627

2.67

28.63

2.5

2.4

3.87

3.57

g/l

1.39

155

596

(3020630) Protein [Mass/volume] in Serum or Plasma

403

2270

1.89

28.29

2.6

2.7

65.27

65.93

g/l

0.86

372

2049

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

157

602

2.69

28.26

1.7

1.3

10.62

10.82

iu/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1386

10762

1.52

27.80

3.1

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

9.79

27.67

2.1

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

225

1031

2.28

27.58

6.6

5.4

0.88

0.06

208

966

(3036489) Thrombin time

189

806

2.43

27.29

2.4

1.9

21.45

21.43

0.01

172

737

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

140

515

2.80

27.29

1.6

1.9

10.53

12.98

mg/l

1.45

133

470

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

141

526

2.76

26.76

1.7

1.4

0.24

g/l

0.35

134

492

(3031040) Bacteria [#/volume] in Urine by Automated count

1845

15288

1.52

26.69

6.1

4.6

610.26

2002.51

e6/l

1.31

249

(3007164) IgA [Mass/volume] in Serum or Plasma

540

3399

1.71

25.96

1.7

1.5

3.01

2.64

g/l

1.19

357

1987

(3004119) Hemoglobin [Mass/volume] in Venous blood

298

1564

2.00

25.67

3.9

3.3

129.47

127.87

g/l

0.52

289

1522

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

446

2670

1.78

25.56

5.1

3.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

443

2.87

25.52

16.5

5.0

184.78

4276.44

iu/ml

0.61

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

889

6358

1.56

25.45

2.5

2.2

3.34

2.97

mg/l

3.37

762

5329

(3017569) Oxygen content in Arterial blood

109

5.02

25.36

2.6

2.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

142

4.44

25.03

1.3

1.1

—

(3039000) Anion gap in Blood

142

553

2.64

24.79

7.2

7.4

11.49

11.27

mmol/l

0.29

126

491

(3018572) Chloride [Moles/volume] in Blood

142

553

2.64

24.79

7.2

7.4

103.79

105.52

mmol/l

3.95

126

491

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

141

551

2.63

24.45

1.7

1.4

1.16

g/l

0.04

133

517

(3007853) Bacteria identified in Skin by Aerobe culture

436

2626

1.77

24.40

2.1

1.8

—

(4062490) Immunoglobulin typing, IgG

138

4.41

24.10

1.2

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

344

3.06

23.91

5.9

2.4

780.33

1378.66

u/ml

—

(3026008) Bacteria identified in Urine by Culture

972

7181

1.52

23.62

3.8

3.2

—

(3015736) pH of Urine

1139

8702

1.49

23.48

4.1

3.4

5.82

5.77

0.09

445

(3027135) IgG subclass 1 [Mass/volume] in Serum

137

4.37

23.42

1.2

1.3

6.90

7.36

g/l

0.27

(3028192) IgG subclass 2 [Mass/volume] in Serum

137

4.37

23.42

1.2

1.3

2.54

2.94

g/l

0.83

(3024139) IgG subclass 3 [Mass/volume] in Serum

137

4.37

23.42

1.2

1.3

0.47

0.42

g/l

0.45

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.57

23.34

2.8

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

240

3.44

22.86

1.5

1.6

0.88

0.92

g/l

0.10

187

(3003434) Protein [Mass/volume] in Pleural fluid

113

408

2.84

22.83

1.3

1.5

32.49

31.28

g/l

0.43

102

358

(3027945) Reticulocytes/100 erythrocytes in Blood

507

3244

1.67

22.67

2.9

2.5

1.88

1.72

2.63

441

2839

(3015377) Calcium [Moles/volume] in Serum or Plasma

1058

8009

1.49

22.62

3.6

3.4

2.34

2.35

mmol/l

0.52

939

6929

(3024928) Oxygen saturation in Venous blood

136

543

2.57

22.59

2.6

3.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

348

2011

1.82

22.28

4.1

4.3

1.21

1.22

mmol/l

1.37

305

1745

(3042733) HLA Ab [Presence] in Serum

6.33

22.26

4.3

4.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

205

986

2.16

22.26

3.2

3.0

0.31

0.33

u/ml

0.51

115

569

(3012441) Differential panel - Pleural fluid

322

3.04

22.13

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1862

15783

1.46

21.69

5.5

4.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

187

3.70

21.48

1.1

—

u/ml

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

206

3.55

21.45

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

206

3.55

21.45

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

206

3.55

21.45

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

1364

10933

1.44

21.32

4.4

3.7

0.00

estimate

1.68

325

2184

(3027273) Bicarbonate [Moles/volume] in Venous blood

242

1265

1.99

21.00

4.7

3.4

25.39

24.85

mmol/l

1.24

235

1228

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1129

8769

1.45

20.69

2.6

2.1

73.73

78.24

nmol/l

5.78

991

7652

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

346

2041

1.78

20.63

1.9

1.7

1.86

1.57

6.43

290

1729

(3009261) Glucose [Presence] in Urine by Test strip

1371

11062

1.43

20.34

4.4

3.7

0.00

estimate

1.08

307

1935

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

136

574

2.43

20.10

1.4

1.6

0.18

11.47

iu/ml

0.62

115

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

261

3.16

20.02

1.3

1.2

3.18

4.60

u/ml

0.72

120

(3021601) Nitrite [Presence] in Urine by Test strip

1352

10919

1.42

19.76

6.0

4.9

0.00

estimate

-0.00

311

2032

(3004588) Protein electrophoresis panel - Serum or Plasma

325

1907

1.79

19.70

2.5

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

132

555

2.44

19.68

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

323

1910

1.77

19.05

4.9

4.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

276

3.02

18.83

1.3

1.2

1.79

3.01

u/ml

0.67

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

222

1176

1.96

18.52

3.5

2.6

0.63

0.65

0.48

222

1169

(3036782) Glucose [Moles/volume] in Pleural fluid

279

2.99

18.49

1.4

6.42

6.44

mmol/l

0.02

260

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1123

8853

1.42

18.40

3.2

2.7

184.81

174.76

ug/l

0.40

1022

7996

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.62

18.20

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

645

4577

1.52

18.19

3.1

3.2

2.48

2.45

mmol/l

8.28

571

4022

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

242

3.11

17.87

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

36.92

17.60

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

174

3.50

17.56

2.4

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.44

17.53

43.2

21.4

169.74

110.22

ug/l

4.35

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

150

702

2.19

17.46

1.7

—

(40768806) Pleura Pathology biopsy report

317

2.79

17.34

1.4

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

127

564

2.31

16.77

2.2

2.7

33.44

34.90

umol/l

0.25

113

505

(3024471) HLA-A [Type]

5.12

15.99

1.0

—

(3024932) HLA-DR beta [Type]

5.12

15.99

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

414

2742

1.59

15.73

3.0

4.2

13.20

25.94

ug/l

0.86

364

2278

(3052851) Hemolysis interference index of Serum or Plasma

150

732

2.10

15.71

4.5

3.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

290

2.77

15.56

5.7

7.9

7.25

7.44

mmol/l

0.19

234

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

211

3.08

15.29

1.2

1.3

19.68

12.99

u/l

0.53

194

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1587

13519

1.36

15.28

3.9

3.1

57.14

56.17

u/l

0.15

1456

12342

(3023199) Leukocytes [#/volume] in Pleural fluid

363

2.55

15.22

1.3

1.4

3504.39

1612.74

e6/l

1.05

256

(3023520) Reticulocytes [#/volume] in Blood

379

2478

1.60

15.18

2.8

2.6

74.14

66.43

e9/l

3.60

267

1897

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.54

15.16

3.0

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.54

15.16

3.0

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

329

2.60

14.60

1.3

1.4

35931.59

91604.02

e6/l

1.02

197

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

272

2.76

14.56

1.2

1.3

430.43

333.37

u/l

0.65

255

(3011397) Hemoglobin [Presence] in Urine by Test strip

696

5223

1.43

14.32

3.8

3.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

423

2879

1.54

14.18

1.2

22.01

12.58

u/ml

1.15

137

1021

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

3.79

13.95

1.2

1.1

4.17

1.55

u/ml

0.52

(3045788) Cell count panel - Pleural fluid

279

2.69

13.89

1.4

—

(3035880) pH of Pleural fluid

164

3.21

13.41

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

407

2.35

13.22

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

170

924

1.89

13.15

2.8

3.8

38.11

57.90

mg/l

1.30

128

760

(40760888) Immunoglobulin light chains.free panel - Serum

137

693

2.02

13.07

2.4

3.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

924

1.88

12.84

2.9

3.8

93.18

64.93

mg/l

0.44

124

756

(40757373) Influenza virus identified in Isolate

5.13

12.68

2.7

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

165

900

1.88

12.64

2.8

3.8

5.44

2.90

ratio

—

(3037756) Immunofixation for Serum or Plasma

122

603

2.07

12.41

1.6

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

326

2.46

12.37

1.2

372.04

271.06

u/ml

1.24

193

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

307

2005

1.59

12.28

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

168

3.07

12.26

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1304

0.37

11.89

2.0

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

143

761

1.92

11.82

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

5.14

11.73

1.2

1.5

—

(40768797) Stomach Pathology biopsy report

426

3020

1.48

11.64

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

356

2.34

11.51

1.4

106.58

133.41

u/ml

0.86

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

197

2.82

11.43

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

137

732

1.91

11.20

2.9

2.4

0.00

g/l

-0.00

127

667

(3003181) Sodium [Moles/volume] in Urine

406

2.23

11.13

1.5

1.3

63.14

63.36

mmol/l

0.02

326

(3017143) Hepatitis C virus Ab [Presence] in Serum

289

1905

1.57

11.09

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

764

6040

1.35

11.09

1.8

1.6

17.44

19.97

nmol/l

6.01

663

5090

(3003888) Timothy IgE Ab [Units/volume] in Serum

3.64

11.06

1.1

1.64

4.94

u/ml

1.23

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

138

743

1.90

11.03

2.9

2.4

0.00

g/l

-0.00

127

668

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

144

788

1.87

10.95

2.8

2.4

0.06

0.03

g/l

0.19

133

710

(3008401) Mugwort IgE Ab [Units/volume] in Serum

3.60

10.90

1.1

2.04

1.05

u/ml

0.46

(44813793) Dust mix specific IgE antibody measurement

4.11

10.86

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

677

5268

1.37

10.85

1.9

1.8

1175.59

1161.74

nmol/l

0.13

507

3903

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

385

2.24

10.83

1.4

1.2

2.87

10.67

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1079

1.73

10.60

2.7

2.5

4.21

3.67

g/l

1.10

167

963

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1079

1.73

10.60

2.7

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1080

1.73

10.57

2.7

2.5

7.74

7.29

g/l

2.93

168

964

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

158

905

1.79

10.38

3.0

2.6

1.61

1.11

g/l

0.41

137

765

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

360

2.25

10.36

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1011

1.74

10.34

2.8

2.6

10.90

10.16

g/l

0.96

158

887

(3021879) Hepatitis B virus core Ab [Presence] in Serum

197

1203

1.68

10.30

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

997

1.75

10.30

2.7

2.5

3.13

2.93

g/l

2.08

156

883

(3028707) Methadone [Presence] in Urine by Screen method

107

3.39

10.26

2.9

2.1

—

(3034426) Prothrombin time (PT)

4.41

10.26

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

318

2.33

10.21

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.72

10.13

1.2

1.05

1.08

ratio

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2391

22222

1.34

10.06

32.4

15.6

29.44

27.75

mg/l

1.49

2216

17803

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.03

10.04

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

329

2.28

9.88

1.4

1.1

39.34

47.01

u/ml

0.20

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1213

10357

1.28

9.81

2.2

2.1

87.81

92.67

pmol/l

3.82

719

5531

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

226

2.55

9.78

1.6

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

925

7632

1.30

9.74

3.1

2.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

137

3.02

9.69

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

132

3.06

9.65

1.7

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

108

561

1.96

9.64

3.0

0.83

0.81

nmol/l

0.16

412

(3004809) Band form neutrophils/100 leukocytes in Blood

438

2.09

9.61

3.3

4.0

1.02

1.51

1.03

376

(3044889) 12 lead EKG panel

1821

16369

1.28

9.59

5.6

4.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

107

3.30

9.57

1.7

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

138

3.00

9.57

1.5

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

195

2.64

9.42

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

469

2.04

9.40

1.5

1.2

3.92

8.54

u/ml

0.69

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

129

3.05

9.38

1.3

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

215

1376

1.60

9.36

1.5

1.7

1.72

1.53

g/l

1.97

181

1170

(3048929) Epstein Barr virus Ab [Presence] in Serum

463

2.04

9.36

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

463

2.04

9.36

1.5

1.2

5.42

3.80

u/ml

0.18

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

144

831

1.77

9.25

2.8

2.3

35.38

37.48

g/l

3.78

129

715

(3000570) Elastase.pancreatic [Mass/mass] in Stool

118

644

1.87

9.10

1.6

1.4

222.73

265.08

ug/g

1.36

387

(3002385) Erythrocyte distribution width [Ratio]

2037

18642

1.27

8.89

35.5

18.7

15.21

15.26

0.16

2013

18219

(3051651) Icteric interference index of Serum or Plasma

150

2.82

8.85

5.2

3.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

129

2.97

8.76

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

100

526

1.93

8.64

1.2

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

175

2.65

8.61

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

181

2.62

8.59

2.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.57

8.58

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

744

6062

1.30

8.40

4.8

4.1

0.01

0.00

estimate

0.25

296

1871

(3051611) Lipemic interference index of Serum or Plasma

250

2.35

8.37

4.6

3.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

3.39

8.34

1.2

1.0

3.48

1.84

u/ml

0.37

(3011412) CD3 cells [#/volume] in Blood

187

2.54

8.06

1.8

2.2

1.02

e9/l

0.02

164

(3011648) Oxygen content in Venous blood

187

2.54

8.06

1.5

2.6

10.17

11.12

0.63

187

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

230

2.37

8.02

1.5

1.7

—

1342.22

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

255

2.30

8.02

1.6

1.3

0.24

0.40

nmol/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.14

7.99

1.0

1.4

71.08

73.53

0.09

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

184

2.52

7.82

1.7

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

339

2.09

7.65

6.4

7.2

12.20

12.26

mg/l

0.04

318

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

255

1777

1.47

7.55

3.9

89.36

97.77

ng/l

0.92

212

1529

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.40

7.52

2.7

2.0

404.00

47511.30

u/ml

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

3.67

7.45

1.2

1.1

—

19.33

u/ml

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.14

7.40

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.14

7.40

1.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.10

7.28

1.3

1.6

—

(3022145) Colonoscopy Study observation

331

2447

1.40

7.10

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

219

2.30

7.01

1.5

1.3

—

nmol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.99

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

833

0.40

6.95

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

614

7458

0.78

6.93

2.6

3.2

0.72

0.83

ug/l

1.96

424

5297

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1240

10930

1.23

6.80

3.2

2.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

695

5756

1.27

6.70

4.6

3.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

336

2522

1.37

6.57

3.1

2.3

9.75

8.06

ug/l

0.72

287

2169

(4035726) Immunohistochemistry procedure

287

2100

1.40

6.54

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

445

1.87

6.54

1.4

1.2

37.69

47.18

u/l

0.40

381

(44816559) Phosphatidylethanol [Mass/volume] in Blood

326

2.02

6.52

1.4

—

(3004451) EKG impression Narrative

130

2.63

6.38

1.4

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.74

6.36

1.1

71.36

80.48

0.55

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

154

2.49

6.35

1.3

1.2

136.25

134.55

titre

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

154

2.49

6.35

1.3

1.2

—

128.00

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1735

15878

1.21

6.33

3.8

3.6

15.20

14.94

pmol/l

3.16

1553

14032

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.15

6.32

1.0

1.2

99.00

107.63

0.49

(21494755) Public health laboratory ask at order entry panel

1070

0.50

6.31

1.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.59

6.31

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

3.59

6.31

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.59

6.31

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.59

6.31

1.1

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

165

1092

1.54

6.29

2.3

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

973

8419

1.23

6.26

4.9

4.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

3.13

6.16

1.2

1.0

1.86

1.43

u/ml

0.20

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

105

625

1.70

6.16

2.1

3.2

1.92

1.71

mg/l

1.50

556

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

705

5900

1.25

6.15

3.0

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

476

3796

1.30

6.15

1.3

1.2

1.72

2.03

u/ml

0.21

107

962

(3000012) Reticulocyte production index

433

1.85

6.13

2.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

762

6452

1.24

5.97

4.3

2.9

2797.97

6034.86

umol/l

1.98

670

5512

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

292

2178

1.38

5.94

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

263

2.07

5.90

1.1

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

160

2.39

5.87

1.3

1.38

0.94

promille

0.82

127

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

476

1.79

5.86

1.9

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

485

1.77

5.80

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

3.16

5.73

1.2

1.1

2.48

2.72

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

152

1016

1.52

5.57

2.0

1.7

—

(3011288) Drugs identified in Urine by Screen method

152

2.38

5.55

5.5

2.5

—

(1761868) Lipid panel - Serum or Plasma

574

6868

0.80

5.50

3.4

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

135

2.46

5.45

4.4

3.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

181

2.23

5.28

2.8

1.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.76

5.20

4.4

4.2

57.40

55.37

0.16

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2071

21905

0.83

5.19

4.6

4.7

4.24

4.44

mmol/l

15.31

1863

19902

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2050

21692

0.83

5.10

4.5

4.7

1.35

1.40

mmol/l

5.33

1825

19543

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

2.45

4.95

1.7

2.0

0.19

0.23

e9/l

0.45

105

(3025941) Bacteria identified in Stool by Culture

155

1070

1.47

4.90

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.78

4.87

1.2

1.3

61.89

282.52

ug/l

0.71

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.56

4.86

1.1

1.2

83.80

79.33

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

372

1.79

4.76

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.43

4.74

1.2

1.1

78.17

80.33

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

302

1.87

4.65

1.1

1.2

167.18

190.27

miu/ml

—

101

(21494814) CD8 cells/100 lymphocytes in Specimen

2.85

4.65

1.5

2.3

—

(3016879) Cocaine [Presence] in Urine

226

2.01

4.60

3.1

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.98

4.55

1.7

2.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

2.34

4.50

1.8

2.0

431.00

435.89

e6/l

0.02

105

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

2.49

4.46

3.2

6.9

75.05

61.57

mg/l

0.49

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

147

1027

1.45

4.40

2.9

3.3

4.22

4.42

pmol/l

1.54

124

879

(3047007) Chlamydophila sp Ab [Presence] in Serum

176

2.12

4.38

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.10

4.36

2.0

1.3

10.20

9.85

ug/l

0.09

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.10

4.36

1.4

1.5

3.42

5.00

0.48

(3017704) Immunofixation for Urine

170

2.13

4.34

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

232

1.95

4.30

1.4

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

11.69

4.27

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

11.69

4.27

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2142

22463

0.85

4.22

5.1

5.3

2.42

2.59

mmol/l

16.12

1923

20284

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.15

4.20

1.2

1.6

75.94

221.12

nmol/24h

0.61

(3016228) CD19 cells/100 cells in Blood

2.67

4.15

1.6

2.3

7.81

8.91

0.19

(3048689) Calprotectin [Mass/mass] in Stool

260

2016

1.32

4.14

2.2

163.64

166.87

ug/g

0.05

208

1587

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

109

2.40

4.14

1.3

1.4

5.45

7.15

u/l

0.92

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.49

4.12

1.3

1.1

—

(3021788) Differential panel - Synovial fluid

414

1.68

4.05

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

189

2.02

4.03

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

6.44

3.98

1.3

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

275

1.83

3.96

3.7

4.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1996

20998

0.86

3.86

4.0

4.2

1.32

1.28

mmol/l

1.93

1760

18764

(3044941) Cell count panel - Synovial fluid

375

1.69

3.83

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

247

3136

0.77

3.82

4.1

4.8

33.43

32.87

0.30

176

2040

(3003327) Ova and parasites identified in Stool by Light microscopy

515

1.59

3.81

1.7

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

101

2.39

3.81

1.1

1.2

234.50

427.24

u/l

0.78

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

140

998

1.42

3.80

3.2

3.3

805.98

4488.16

u/ml

0.71

121

868

(3026389) Candida sp identified in Specimen by Organism specific culture

229

1.89

3.78

1.5

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

4.60

3.74

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

2.18

3.73

1.8

2.8

44.77

37.45

1.06

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.65

3.72

1.8

1.7

96.42

88.62

umol/l

0.08

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

936

10388

0.86

3.72

4.1

4.6

21.81

22.25

0.36

443

5501

(3027008) Opiates [Presence] in Urine

252

1.84

3.71

3.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

253

1.83

3.67

3.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

248

1.83

3.57

3.1

1.5

—

(3010503) CD19 cells [#/volume] in Blood

130

2.16

3.57

1.8

2.2

0.12

0.16

e9/l

0.42

124

(3000093) Morphology [Interpretation] in Blood Narrative

263

1.80

3.56

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

549

1.54

3.53

1.2

608.33

1374.38

titre

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.31

3.51

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.02

3.49

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

617

5366

1.19

3.49

1.7

11277032.49

32304562.69

pmol/l

0.88

470

4340

(3036180) Methadone [Presence] in Urine

3.62

3.49

2.1

1.4

—

(3008295) Osmolality of Serum or Plasma

230

1.84

3.42

1.2

1.3

274.83

278.65

mosm/kgh2o

0.42

173

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

253

1.79

3.37

1.2

1.3

227.35

276.68

pmol/l

0.52

221

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

244

1936

1.28

3.31

3.3

2.7

62.61

62.70

ml/min/173m2

0.01

102

809

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

100

689

1.47

3.30

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.93

3.29

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

212

1.85

3.26

1.6

1.4

23.42

22.27

0.08

130

(3000060) B lymphocytes [#/volume] in Blood

3.34

3.22

1.8

2.0

100.00

157.78

e6/l

—

(40768800) Prostate Pathology biopsy report

858

0.61

3.21

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

644

1.47

3.20

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

250

1.77

3.20

3.1

1.7

—

(36660697) Celiac disease serology panel - Serum

178

1364

1.32

3.14

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

1.60

3.09

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

181

1.89

3.05

2.0

1.5

26.71

22.08

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.56

2.99

1.1

1.2

1.99

1.85

umol/24h

0.17

(3001729) Color of Synovial fluid

3.85

2.98

1.3

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.83

2.91

1.5

1.4

0.30

0.44

ug/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

536

0.54

2.90

1.6

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

576

1.47

2.88

1.7

1.6

14539.07

14006.52

e6/l

0.04

406

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.65

2.79

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

277

1.67

2.77

1.2

1.4

76.74

75.83

mu/l

0.01

243

(3042111) Morphology [Interpretation] in Bone marrow Narrative

492

1.50

2.74

1.3

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

6.01

2.70

1.2

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

148

1.90

2.60

1.3

1.1

—

5.17

—

(40768441) Liver Pathology biopsy report

149

1.89

2.55

1.1

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.13

2.54

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

129

1.95

2.50

1.0

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

129

1.95

2.50

1.0

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.11

2.48

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2083

20016

1.13

2.45

4.8

4.3

1.96

2.19

mu/l

1.34

1865

17791

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

2.42

0.0

3.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.34

2.39

4.2

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

235

1.67

2.38

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

168

1.79

2.36

3.0

1.7

6.75

6.77

mmol/l

0.02

115

(3052592) Norovirus Ag [Presence] in Stool

2.61

2.35

1.0

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

244

1.65

2.34

2.9

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

372

1.51

2.30

1.3

7.45

9.29

u/l

0.83

296

(3019832) Treponema pallidum Ab [Presence] in Serum

104

778

1.35

2.25

1.3

1.4

—

(4146454) Self-monitoring of blood glucose

312

0.48

2.23

2.4

2.5

—

(3017732) Neutrophils [#/volume] in Blood

177

1426

1.26

2.21

2.9

3.3

7.20

5.52

e9/l

0.38

139

1063

(21494890) Protein electrophoresis panel - 24 hour Urine

296

1.56

2.19

2.1

2.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.51

2.18

1.2

1.3

—

115.90

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

1.89

2.16

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

122

1.89

2.16

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

122

1.89

2.16

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

116

890

1.32

2.13

2.7

3.0

0.26

0.33

g/l

0.77

378

(3007566) Smooth muscle Ab [Titer] in Serum

548

1.40

2.08

1.3

1.2

71.00

84.86

titre

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2131

22006

0.90

2.07

4.8

4.9

6.06

6.10

mmol/l

0.55

1899

19599

(3033705) Calcium.ionized [Moles/volume] in Venous blood

357

1.49

2.07

3.4

2.4

—

(3019150) Specific gravity of Urine by Refractometry

545

4883

1.14

2.07

4.9

4.1

1.02

kg/l

0.07

750

(3011436) Histone Ab [Units/volume] in Serum

2.71

2.07

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

124

1.86

2.06

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

124

1.86

2.06

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

124

1.86

2.06

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

125

1.85

2.02

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

275

3213

0.84

2.02

10.4

7.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.08

2.01

1.0

1.3

—

mmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.08

2.01

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

133

1673

0.79

2.01

1.6

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.75

1.93

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

659

1.35

1.93

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.45

1.93

1.0

1.3

116.09

109.89

0.38

(3016650) Hepatitis A virus Ab [Presence] in Serum

307

1.51

1.90

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1222

12938

0.91

1.89

4.5

5.4

2.90

4.27

ug/l

1.56

1045

11489

(3017354) Segmented neutrophils/100 leukocytes in Blood

276

1.53

1.87

2.7

4.0

60.27

55.12

0.96

227

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.85

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

101

1.89

1.80

1.4

0.57

3.74

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.27

1.80

1.6

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.76

1.79

1.0

1.1

—

(40768443) Skin Pathology biopsy report

127

1013

1.26

1.78

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

420

1.41

1.78

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

154

1.69

1.76

2.7

2.9

—

(3028433) Virus identified in Specimen by Culture

2.09

1.75

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.92

1.72

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

1.77

1.71

1.8

2.1

—

(3044927) Protein electrophoresis panel - Urine

307

1.47

1.70

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.30

1.70

1.9

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

588

1.33

1.68

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.19

1.67

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.16

1.66

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

584

1.33

1.60

1.3

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

533

0.67

1.60

1.7

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.00

1.58

1.3

1.7

15.30

18.10

umol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

579

1.32

1.54

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

317

1.43

1.48

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

368

1.39

1.47

2.5

3.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.23

1.46

1.1

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

228

1.50

1.43

1.3

24413.33

128202.58

e6/l

1.41

166

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.31

1.43

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

111

1.72

1.39

1.1

1.2

152.42

135.20

nmol/l

0.56

111

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.20

1.37

1.8

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.94

1.36

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.94

1.36

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.87

1.34

1.1

1.2

36.00

39.15

g/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.92

1.33

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.78

1.33

2.2

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

360

1.37

1.30

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

429

1.33

1.30

1.8

1.7

4.71

5.04

iu/l

0.08

126

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

355

0.65

1.30

1.8

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.78

1.28

1.6

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

114

1.67

1.28

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

114

1.67

1.28

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.94

1.27

1.1

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

353

1.37

1.27

1.4

1.8

280.90

299.12

mu/l

0.24

330

(3006922) Hepatitis E virus Ab [Presence] in Serum

122

1.64

1.27

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.05

1.26

1.0

17.84

16.78

umol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.91

1.22

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

237

1.44

1.22

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.63

1.21

1.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

272

1.40

1.19

1.4

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.75

1.19

3.3

2.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.31

1.18

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.31

1.18

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

730

1.24

1.18

1.4

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

377

1.33

1.15

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

274

1.39

1.15

1.5

61.16

64.67

0.21

167

(3002079) Sodium [Moles/time] in 24 hour Urine

1.81

1.15

1.2

130.38

168.45

mmol/24h

1.26

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.85

1.13

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

293

1.37

1.11

1.8

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.38

1.09

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

218

1.43

1.09

1.4

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

(21494434) Karyotype in Bone marrow

270

1.37

1.06

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2068

21142

0.93

1.05

6.2

6.3

41.21

40.72

mmol/mol

1.43

1872

19188

(3014891) Appearance of Pleural fluid

1.96

1.03

1.0

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.06

1.02

1.4

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

333

1.33

1.02

3.0

2.0

30.50

25.13

mg/l

0.27

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.89

1.01

2.7

2.0

128.80

151.60

nmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

139

1.51

1.00

1.6

1.7

2.67

1.74

u/field

0.29

(3016018) Differential panel - Cerebral spinal fluid

214

1.41

0.99

1.5

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

503

1.26

0.98

1.6

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.71

0.98

4.3

7.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.18

0.98

1.0

1.2

9.80

13.04

u/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

100

1.60

0.96

1.3

2.3

244.00

7552.51

e6/l

—

(40768795) Lymph node Pathology biopsy report

200

1.40

0.93

1.2

—

(1002224) Polysomnography panel

607

1.22

0.93

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.61

0.87

2.8

1.9

38.13

57.13

u/l

0.36

(3044007) Cell count panel - Peritoneal fluid

1.67

0.85

1.2

2.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

469

1.24

0.84

1.7

1.4

4702.51

740.96

e6/l

0.69

387

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

162

1.42

0.84

1.2

—

(3023410) Appearance of Cerebral spinal fluid

196

1.38

0.84

2.3

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

470

1.24

0.83

1.6

1.4

5.86

26.05

e6/l

0.92

371

(3013512) EKG study

796

7593

1.07

0.82

5.6

4.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

801

1.18

0.82

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

1.39

0.81

1.0

1.1

—

(3024263) Appearance of Synovial fluid

138

1.45

0.81

1.2

1.4

—

(40768793) Breast Pathology biopsy report

341

0.73

0.81

1.2

1.3

—

(3016750) Collection duration of Urine

155

1.42

0.81

2.1

2.0

501.80

496.74

min

—

108

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2402

23671

1.07

0.79

35.8

18.7

138.91

139.72

mmol/l

35.45

2358

22982

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.78

1.6

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.67

0.78

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.78

0.0

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.78

0.0

1.5

—

7.43

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.62

0.78

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

594

1.20

0.77

2.6

3.4

256.38

1027.88

u/ml

0.90

558

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

290

0.72

0.75

1.2

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

149

1327

1.13

0.73

2.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.84

0.73

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

811

1.16

0.72

1.4

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.61

0.72

1.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.62

0.71

1.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.75

0.71

2.6

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.75

0.71

1.0

1.1

—

(3012516) Albumin [Mass/volume] in Urine

808

7747

1.06

0.71

3.0

3.3

582.90

311.63

mg/l

0.82

558

5068

(3009508) Creatinine [Moles/volume] in Urine

823

7899

1.06

0.69

3.1

3.2

7.33

7.67

mmol/l

1.41

701

6507

(3023103) Potassium [Moles/volume] in Serum or Plasma

2404

23721

1.06

0.69

35.8

18.9

4.02

4.01

mmol/l

1.77

2355

22998

(3051387) C reactive protein [Mass/volume] in Capillary blood

537

1.20

0.69

6.3

3.3

32.07

32.00

mg/l

0.01

344

(3005570) Glucose [Moles/volume] in Urine

239

1.30

0.69

2.0

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.85

0.68

4.8

5.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.56

0.68

1.6

1.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

102

1.47

0.67

1.5

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

102

1.47

0.67

1.5

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.61

0.65

1.5

1.8

—

(3049717) Cytology report of Urine Cyto stain

149

1341

1.12

0.64

2.7

2.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

305

1.25

0.63

1.3

30.90

31.15

iu/l

0.01

254

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

101

0.59

0.62

1.5

1.3

1.49

1.53

g/l

—

101

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.67

0.61

3.4

2.9

—

(4212803) Bone marrow aspirate examination

1.67

0.61

1.2

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.61

2.6

2.5

0.40

0.33

u/field

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.60

0.61

1.0

1.2

—

(40761511) CBC panel - Blood by Automated count

2319

22890

1.05

0.60

26.1

15.2

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.72

0.57

1.7

—

(3045142) Bone marrow Pathology biopsy report

319

1.23

0.57

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

107

1.40

0.55

2.1

1.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

339

1.21

0.54

1.0

1.1

13.90

65.23

iu/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

697

0.86

0.54

2.0

2.2

93.72

95.91

ug/min

0.02

417

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.58

0.54

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

126

0.63

0.54

1.1

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

2428

24529

0.95

0.53

42.5

23.3

133.12

134.85

g/l

5.45

2390

24026

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.54

0.53

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

108

1.39

0.53

4.7

6.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.52

0.52

1.7

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.52

0.52

4.2

7.3

—

(3026361) Erythrocytes [#/volume] in Blood

2428

24523

0.95

0.51

42.0

23.2

4.41

4.44

e12/l

2.00

2351

23635

(3024731) MCV [Entitic volume]

2428

24522

0.95

0.51

41.9

23.1

92.46

91.70

10.69

2391

24022

(3035941) MCH [Entitic mass]

2428

24521

0.95

0.51

41.9

23.1

30.52

30.54

0.26

2391

24020

(3007461) Platelets [#/volume] in Blood

2428

24518

0.95

0.50

42.1

23.2

257.24

235.35

e9/l

34.95

2364

23717

(3010813) Leukocytes [#/volume] in Blood

2429

24525

0.95

0.49

42.0

23.2

8.13

6.78

e9/l

69.09

2354

23636

(1761482) Bacteria [#/volume] in Urine by Culture

746

1.13

0.49

5.7

3.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

108

974

1.11

0.49

1.3

1.2

152.10

133.17

iu/ml

0.12

343

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

486

1.15

0.46

1.3

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

844

8193

1.04

0.46

3.5

3.9

13.60

9.67

mg/mmol

1.16

569

5296

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

176

0.74

0.46

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

610

5881

1.05

0.45

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.59

0.45

1.0

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2428

24500

0.96

0.45

43.0

23.3

39.71

39.80

0.27

2226

22578

(4281824) Cell count and differential, peritoneal fluid

183

1.26

0.44

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.40

0.44

1.4

2.1

9472.86

24045.71

e6/l

—

(3004775) Volume in Urine collected for unspecified duration

229

1.22

0.43

2.1

2.2

505.67

640.11

1.41

140

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.61

0.43

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.63

0.42

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

176

1.25

0.41

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

158

1.27

0.41

5.2

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.38

0.41

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.38

0.41

1.0

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

2.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

213

1.22

0.40

1.8

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

159

1.26

0.40

2.0

1.5

136.20

99.28

umol/l

0.40

159

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

48.43

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.36

0.40

1.7

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.43

0.39

12.8

11.1

5.48

5.62

mmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

105

0.67

0.39

1.3

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.0

—

(3045424) Erythrocytes [Presence] in Urine

388

0.85

0.38

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

326

1.17

0.38

2.6

2.2

9.44

185.40

u/ml

0.81

321

(40761535) Cells panel - Urine sediment

223

2106

1.06

0.37

3.9

3.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.65

0.35

1.6

2.2

—

(3006462) Nitrate [Presence] in Urine

117

1.28

0.35

2.2

3.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.36

0.34

1.0

1.1

—

3.10

—

(3033799) Differential panel - Peritoneal fluid

1.34

0.34

1.5

2.0

—

(3045414) Leukocytes [Presence] in Urine

1039

0.92

0.32

2.2

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

332

1.15

0.32

1.8

2.6

0.64

1.46

g/24h

2.17

161

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

174

1.21

0.31

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

147

1.23

0.30

2.0

1.8

4126.42

3468.38

u/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

630

0.90

0.30

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

214

2039

1.05

0.29

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

919

0.92

0.28

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

918

9004

1.03

0.28

2.3

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

803

0.92

0.27

1.1

1.0

—

(3003338) MCHC [Mass/volume]

1812

17935

1.02

0.27

39.5

20.7

329.61

332.54

g/l

29.11

1797

17742

(3038177) Helicobacter pylori Ab [Presence] in Serum

271

1.15

0.27

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

160

1.19

0.25

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

160

1.19

0.25

1.7

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.27

0.24

1.1

1.3

—

(40768446) Kidney Pathology biopsy report

0.71

0.24

3.3

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

351

1.11

0.23

1.7

1.8

4.02

4.76

mmol/24h

0.89

303

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

136

0.81

0.23

1.3

1.9

16.55

15.33

nmol/l

0.16

125

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.28

0.23

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

650

1.08

0.22

2.7

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

295

0.88

0.22

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.74

0.22

1.0

1.1

—

258.19

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

206

2140

0.96

0.21

2.3

2.1

13.74

12.14

nmol/l

1.20

169

1872

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3008898) HLA-B27 [Presence]

430

1.09

0.21

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

101

0.79

0.21

1.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

154

1.17

0.21

1.7

1.8

—

(3002619) Bacteria identified in Specimen by Culture

1.16

0.21

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.16

0.21

2.0

1.6

115.20

185.29

ng/l

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.21

0.0

1.0

—

77.63

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

108

1.20

0.20

2.3

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.13

0.18

5.3

7.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

133

1387

0.96

0.18

2.2

2.4

9.40

20.13

au/ml

—

(3019225) pH of Specimen

266

2586

1.03

0.17

4.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.22

0.17

1.5

1.2

—

(3002256) Pathology report gross observation

313

3208

0.97

0.17

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.73

0.17

1.0

2272.60

1673.63

miu/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

297

0.91

0.15

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.76

0.15

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

138

1330

1.04

0.15

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

605

0.94

0.15

1.4

1.7

51.73

43.25

nmol/l

0.80

579

(3003740) Influenza virus B Ag [Presence] in Specimen

179

1.12

0.14

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2384

23758

1.01

0.12

15.1

10.8

25.41

26.48

u/l

0.95

2318

22665

(3000330) Specific gravity of Urine by Test strip

139

1350

1.03

0.11

5.1

3.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

301

0.93

0.10

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

1.13

0.10

1.4

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.06

0.09

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2111

21177

0.99

0.09

29.0

15.3

75.68

74.58

ml/min/173m2

1.39

1819

17540

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.13

0.09

1.3

1.1

1.05

1.22

u/l

—

(3020650) Glucose [Presence] in Urine

1.07

0.08

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.78

0.08

1.0

2.1

3.64

1.09

ug/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.06

0.08

1.6

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

599

5937

1.01

0.08

1.8

1.6

1.39

1.33

mmol/l

0.93

502

4890

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.81

0.07

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.07

0.07

1.0

—

(3022621) pH of Urine by Test strip

163

1603

1.02

0.06

2.9

3.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

179

1.06

0.04

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

0.93

0.04

1.8

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2383

23797

1.01

0.04

34.3

18.9

86.25

85.57

umol/l

0.27

2383

23787

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

129

0.93

0.03

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

129

0.93

0.03

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

131

1.07

0.03

1.1

—

7.11

—

(3051593) INR in Capillary blood by Coagulation assay

149

0.94

0.03

5.3

14.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.09

0.03

1.3

1.2

106.80

251.40

iu/ml

—

(4034850) Laboratory test

700

0.99

0.02

13.8

11.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

479

0.98

0.02

1.2

1.4

0.77

0.82

nmol/l

0.26

394

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

0.94

0.01

1.4

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

237

0.97

0.01

2.3

3.3

153.76

30.69

mg/l

0.71

197

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

120

1.00

0.00

1.1

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

118

1.02

0.00

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

293

0.99

0.00

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

293

0.99

0.00

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

293

0.99

0.00

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

117

1.03

0.00

8.7

5.5

55.40

64.15

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

235

1.02

0.00

1.9

1.36

2.13

u/field

0.79

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.14

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.1

—

1.33

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.0

—

890.60

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.06

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

587.96

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.3

—

3.03

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

4.96

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3048879) Bone marrow aspiration report

1.00

-0.00

1.1

1.6

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

6.7

—

59.17

—

(40765096) Chromosome analysis panel by Banding

0.91

-0.00

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.00

-0.00

1.0

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.86

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(3015183) Erythrocyte sedimentation rate

0.93

-0.00

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.00

-0.00

1.2

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

7.93

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_EMPHYSEMA and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_EMPHYSEMA	3.684 [3.14, 4.33]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 1167 out of 3260 females with J10_EMPHYSEMA died.

Males

Parameter	HR [95% CI]	p-value
J10_EMPHYSEMA	3.237 [2.81, 3.72]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3606 out of 7590 males with J10_EMPHYSEMA died.

Mortality risk

Mortality risk for people of age

years, who have J10_EMPHYSEMA.

N-year risk	Females	Males
1	0.307%	0.643%
5	1.856%	3.69%
10	4.444%	8.79%
15	8.028%	16.011%
20	13.584%	25.898%

Relationships between endpoints

↥

Index endpoint: J10_EMPHYSEMA – Emphysema

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Emphysema

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints